Literature DB >> 16102469

Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation.

Sotiria C Apostolopoulou1, John Papagiannis, Spyridon Rammos.   

Abstract

We present a 14-year-old pre-transplant boy with elevated pulmonary pressure and plastic bronchitis after Fontan operation despite stent fenestration, who improved with long-term oral administration of the endothelin antagonist, bosentan. Bosentan improved the patient's symptoms and aortic saturation, World Health Organization class, maximal and sub-maximal exercise capacity, Borg dyspnea index, invasively measured mean pulmonary pressure, pulmonary blood flow and pulmonary vascular resistance. This is the first literature report examining the effect of endothelin antagonism in failing Fontan circulation and showing clinical, exercise and hemodynamic improvement with bosentan in a pre-transplant Fontan patient with high pulmonary pressure and plastic bronchitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16102469     DOI: 10.1016/j.healun.2004.11.018

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  15 in total

1.  Sildenafil Increases Systemic Saturation and Reduces Pulmonary Artery Pressure in Patients with Failing Fontan Physiology.

Authors:  Gira S Morchi; D Dunbar Ivy; Mark C Duster; Lori Claussen; Kak-Chen Chan; Joseph Kay
Journal:  Congenit Heart Dis       Date:  2009-04       Impact factor: 2.007

2.  Predictors of sildenafil effects on exercise capacity in adolescents and adults with Fontan circulation.

Authors:  Alfred Hager; Ruth Weber; Jan Müller; John Hess
Journal:  Clin Res Cardiol       Date:  2014-03-18       Impact factor: 5.460

3.  A multifaceted approach to the management of plastic bronchitis after cavopulmonary palliation.

Authors:  Catherine M Avitabile; David J Goldberg; Kathryn Dodds; Yoav Dori; Chitra Ravishankar; Jack Rychik
Journal:  Ann Thorac Surg       Date:  2014-05-17       Impact factor: 4.330

Review 4.  Drug treatment of pulmonary hypertension in children.

Authors:  Erika E Vorhies; David Dunbar Ivy
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

Review 5.  Successful management of plastic bronchitis in a child post Fontan: case report and literature review.

Authors:  Paul Do; Inderpal Randhawa; Terry Chin; Kourosh Parsapour; Eliezer Nussbaum
Journal:  Lung       Date:  2012-03-20       Impact factor: 2.584

6.  Importance of dynamic central venous pressure in Fontan circulation.

Authors:  JeongHye Kim; Seiko Kuwata; Clara Kurishima; Yoichi Iwamoto; Hirotaka Ishido; Satoshi Masutani; Hideaki Senzaki
Journal:  Heart Vessels       Date:  2018-01-08       Impact factor: 2.037

Review 7.  Hypoplastic left heart syndrome: current considerations and expectations.

Authors:  Jeffrey A Feinstein; D Woodrow Benson; Anne M Dubin; Meryl S Cohen; Dawn M Maxey; William T Mahle; Elfriede Pahl; Juan Villafañe; Ami B Bhatt; Lynn F Peng; Beth Ann Johnson; Alison L Marsden; Curt J Daniels; Nancy A Rudd; Christopher A Caldarone; Kathleen A Mussatto; David L Morales; D Dunbar Ivy; J William Gaynor; James S Tweddell; Barbara J Deal; Anke K Furck; Geoffrey L Rosenthal; Richard G Ohye; Nancy S Ghanayem; John P Cheatham; Wayne Tworetzky; Gerard R Martin
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

8.  The Fontan pathway: What's down the road?

Authors:  Sachin Khambadkone
Journal:  Ann Pediatr Cardiol       Date:  2008-07

Review 9.  Drug Treatment of Pulmonary Hypertension in Children.

Authors:  Catherine M Avitabile; Erika E Vorhies; David Dunbar Ivy
Journal:  Paediatr Drugs       Date:  2020-04       Impact factor: 3.022

Review 10.  Current challenges in pediatric pulmonary hypertension.

Authors:  Shinichi Takatsuki; David Dunbar Ivy
Journal:  Semin Respir Crit Care Med       Date:  2013-09-13       Impact factor: 3.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.